Acupoint Massage Combined With Ear Point Pressing Beans

Explore the Application Effect of Acupoint Massage Combined With Ear Point Pressing Beans in the Remission Stage of Asthma

Objective: To explore the application effect of acupoint massage combined with ear point pressing beans in the remission stage of asthma. Methods: 120 children with asthma in remission who were treated in pediatric outpatient department from January 2016 to October 2022 were randomly divided into experimental group and control group, with 60 cases in each group.The patients in both groups were treated with salmeterol and fluticasone inhalation powder once a day, twice a day. The patients in the control group were treated with acupoint massage on this basis. Acupoint massage once a day from Monday to Friday, lasting for 30 minutes each time.The patients in the experimental group were treated with ear point pressing beans on the basis of the control group. The ear point pressing beans is performed once a day from Monday to Friday. Changes in pulmonary function and asthma control were observed before and after treatment in the two groups were observed, and forced expiratory volume 1 second (FEV1),forced expiratory vital capacity (FVC), FEV1/FVC, asthma control test scale (ACT) score were compared.

Study Overview

• Status: Completed
• Conditions: Asthma
• Intervention / Treatment: Behavioral: the experiment group were treated acupoint massage combined with ear point pressing beans; Behavioral: the control group were treated with acupoint massage

• Study Type: Interventional
• Enrollment (Actual): 120
• Phase: Phase 1

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• The patient met the diagnostic criteria of asthma remission in the Guidelines for prevention and treatment of bronchial asthma；
• 1~18 years old, course of disease > 1 year;
• Patients with complete clinical data and able to cooperate with treatment.

Exclusion Criteria:

• Patients with other cardiopulmonary system diseases or myasthenia gravis;
• Eczema, ulcer or other symptoms in the auricle or skin;
• Illiteracy, cognitive, language or communication disorders;
• The patient has taken medication for asthma treatment within 3 months.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: control group	Behavioral: the control group were treated with acupoint massage; Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation was used 1 puff each time, 2 times/d. On this basis, patients in the control group were treated with acupoint massage.
Experimental: experiment group	Behavioral: the experiment group were treated acupoint massage combined with ear point pressing beans; Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation was used 1 puff each time, 2 times/d. Patients in the experiment group were treated with auricular point pressing on basis if the treatment of the control group. Selecting 10 acupoints including Tanzhong, Tiantu, Dingchuan(both sides), Feishu(both sides), Yuji(both sides), and Lieque(both sides), and massage each acupoint for about 3 minutes. Acupoint massage once a day from Monday to Friday, lasting for 30 minutes each time. Selecting the Fengxi(both sides), Lung(both sides), Bronchial(both sides), and Shenmen(both sides) acupoints on the ear for ear point pressing beans. The operator rubs the above acupoints with their hands for about 5 minutes, and then performs ear point pressing beans on these 4 acupoints. The ear point pressing beans is performed once a day from Monday to Friday.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Pulmonary function	Forced expiratory vital capacity (FVC), FEV 1 and FEV1/FVC ratio were measured with Jaeger pulmonary function testing instrument	1 minutes
Asthma control	The Asthma Control test Scale (ACT) was used for assessment, including daily life status, dyspnea times, asthma symptoms, emergency medication use, and asthma control. Each item was 1 to 5 points, and the total score was 5 to 25 points.	1 hour
Efficacy assessment	Complete control: no symptoms occurred throughout the day after treatment, no significant limitation of activity, no acute attack, PEF or FEV1 normal value or ≥ normal expected value; Partial control: after treatment, symptoms> 2 times/week during the day, wake up at night, mild limitation of activity. Drug relief is required for over 2 times/week; Uncontrolled: frequent symptoms during the day and at night, limited activity, acute attacks. Drugs should be used frequently for relief. Total control rate = complete control rate + partial control rate.	1 hour

Collaborators and Investigators

• Sponsor: Hai'an Hospital of TCM001

Study record dates

Study Major Dates

• Study Start (Actual): January 1, 2016
• Primary Completion (Actual): October 1, 2022
• Study Completion (Actual): December 1, 2022

Study Registration Dates

• First Submitted: October 18, 2024
• First Submitted That Met QC Criteria: October 18, 2024
• First Posted (Actual): October 21, 2024

Study Record Updates

• Last Update Posted (Actual): October 21, 2024
• Last Update Submitted That Met QC Criteria: October 18, 2024
• Last Verified: October 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Respiratory Tract Diseases; Immune System Diseases; Lung Diseases; Hypersensitivity, Immediate; Bronchial Diseases; Lung Diseases, Obstructive; Respiratory Hypersensitivity; Hypersensitivity; Asthma
• Other Study ID Numbers: Hai'an Hospital of TCM001

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No